New Two-Drug attack on advanced kidney cancer begins testing
NCT ID NCT07159191
Summary
This study is testing whether combining two different types of cancer drugs works better than current options for advanced kidney cancer. About 30 patients who haven't had prior treatment will receive both an immunotherapy injection and a targeted therapy pill. Researchers will track how well the combination shrinks tumors, controls cancer growth, and what side effects patients experience.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED RENAL CELL CARCINOMA (ARCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.